RAC - Charts & Price Action, page-2907

First 2907 Last

Share
Profile

Follow
johndprent

2,810 Posts.

3433

07/01/21

20:12

Post #: 50017733
Share

Originally posted by Aqua65: ↑

I would note - to take into account that everything changed , *RAC re-rate from late June / into July when also the COH study on bisantrene came to light .
( they had gone to such lengths to seek to disguise bisantrene as the drug - but in major publications , the actual drug names / identify must be given and used . )
This was significant work by COH .

The Sheba trial results were chosen as a paper / poster presentation at the ASH conference at the end of 2020 also.

My point is that late June & into July 2020 was a major turning point for RAC : really like a new starting point for your charts - joining fundamentals with TA .
1. The Sheba trial results (June 2020) ; &
2. the City of Hope findings that Bisantrene was No 1 out of over 250000 drug compounds for the inhibition of the FTO protein , that is significant in a broad number of cancers.
This really helps explain Bisantrenes known historical efficacy in breast, AML, renal , ovarian , lung , and other difficult cancers including melanoma, where other chemotherapy and treatments have failed & where the FTO protein is now being focused on as a potential target in these cancers .

This would all still fit with your possible theory

Expand

I hadn't chartered every positive announcement but I suppose COH is probably worthwhile - even if the market didn't (hasn't?) considered the value of such information.

The reason behind posting this is not to insinuate foul-play - rather that well timed dilution events can have significant upside to the share price and keep momentum pulsing.

RAC Price at posting: $1.73 Sentiment: Buy Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

RDN

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

TAT

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

ASX

ASX explains: How 'futures' are predicted

GMD

Genesis set for higher gold production in FY25 and earlier mill start

There are more pages in this discussion • 19,185 more messages in this thread...

First 2907 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.71		Change 0.010(0.59%)		Mkt cap ! $291.3M

Open	High	Low	Value	Volume
$1.76	$1.79	$1.66	$307.6K	176.7K

Buyers (Bids)

No.	Vol.	Price($)
1	615	$1.62

Sellers (Offers)

Price($)	Vol.	No.
$1.74	609	1

View Market Depth

No.	Vol.	Price($)
1	615	1.620
1	12000	1.615
1	20000	1.610
3	21625	1.600
1	1279	1.555

Price($)	Vol.	No.
1.735	609	1
1.800	13808	4
1.820	4000	3
1.830	4000	1
1.850	14401	2

Last trade - 16.10pm 02/09/2024 (20 minute delay)

RAC (ASX) Chart

RAC - Charts & Price Action, page-2907

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

ASX explains: How 'futures' are predicted

Genesis set for higher gold production in FY25 and earlier mill start

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

RAC - Charts & Price Action, page-2907

Top Stories

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

ASX explains: How 'futures' are predicted

Genesis set for higher gold production in FY25 and earlier mill start

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News